PR Newswire - Immune Mediated Disease Therapeutics Developer Att...
SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, ...
Read More


ภาษาไทย
English